<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-08-00197-f006" orientation="portrait" position="float">
 <label>Figure 6</label>
 <caption>
  <p>Cross-reactivity of the recombinant vaccine candidates against group 2 hemagglutinins. Breadth of the antibody response elicited by the immunization of BALB/c mice (
   <italic>n</italic> = 6) with the vaccine prototypes was determined by ELISA against a panel of full-length recombinant HA proteins: (
   <bold>A</bold>) H3N2 A/Wyoming/3/2003; (
   <bold>B</bold>) H4N6 A/red knot/Delaware/541/1988; (
   <bold>C</bold>) H7N9 A/Shanghai/1/2013; (
   <bold>D</bold>) H10N8 A/Jiangxi-Donghu/346/2013. The dotted line indicates the limit of antibody detection; error bars represent mean ± SD. Statistical analysis was performed using one-way ANOVA followed by a Tukey’s multiple comparison test (** 
   <italic>p</italic> &lt; 0.01; *** 
   <italic>p</italic> &lt; 0.001; **** 
   <italic>p</italic> &lt; 0.0001).
  </p>
 </caption>
 <graphic xlink:href="vaccines-08-00197-g006" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
